Biotech Values

[DewDiligence]

Brugger has three months from the date of resignation (i.e. until 2/5/11) to exercise his remaining options. This applies to both ISO’s and non-ISO’s.

Following his recent exercise of 55,730 options at an exercise price of $0.23, Brugger continues to hold 97,648 vested options, all of which are in-the-money:

15,625 options exercisable @$5.16 (62.5% vesting of 25,000 options)
25,000 options exercisable @$6.88 (fully vested)
22,500 options exercisable @$7.41 (56.25% vesting of 40,000 options)
10,828 options exercisable @$10.43 (31.25% vesting of 34,650 options)
18,281 options exercisable @$12.81 (81.25% vesting of 22,500 options)
05,414 options exercisable @$15.37 (12.5% vesting of 43,313 options)

Source: http://sec.gov/Archives/edgar/data/1235010/000104746910004249/a2198205zdef14a.htm (page 32)
http://sec.gov/Archives/edgar/data/1235010/000117911010003337/xslF345X03/edgar.xml
http://sec.gov/Archives/edgar/data/1235010/000104746904026628/a2141821zex-10_1.htm
http://sec.gov/Archives/edgar/data/1235010/000104746904026628/a2141821zex-10_2.htm